Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Combujet-3 Rifampicin Isoniazid And Ethambutol Tablet:
Combujet-3 is a combination medication containing Rifampicin, Isoniazid, and Ethambutol, formulated as tablets. Each tablet typically contains Rifampicin 150 mg, Isoniazid 75 mg, and Ethambutol 275 mg. It is prescribed for the treatment of tuberculosis (TB).
Uses of Combujet-3 Rifampicin Isoniazid And Ethambutol Tablet:
Combujet-3 is used for the treatment of:
Active tuberculosis infections caused by Mycobacterium tuberculosis.
Prophylaxis in individuals exposed to tuberculosis.
Benefits of Combujet-3 Rifampicin Isoniazid And Ethambutol Tablet:
Effective Treatment: Combujet-3 combines multiple antitubercular agents to target different stages of tuberculosis infection, enhancing efficacy.
Reduction of Drug Resistance: Use of multiple drugs reduces the risk of developing drug-resistant TB strains.
Convenience: Provides a convenient once-daily dosing regimen for tuberculosis treatment.
Mechanism of Action of Combujet-3 Rifampicin Isoniazid And Ethambutol Tablet:
Rifampicin: Inhibits RNA synthesis in Mycobacterium tuberculosis by binding to the beta subunit of RNA polymerase.
Isoniazid: Inhibits mycolic acid synthesis, essential for the cell wall of Mycobacterium tuberculosis.
Ethambutol: Inhibits arabinosyl transferase enzyme, necessary for cell wall synthesis in Mycobacterium tuberculosis.